title: Is postexposure prophylaxis with antiretroviral therapy necessary in cases of blood exposure through a fight when HIV-1 status is unknown?
authors.affiliation: aEA 3620 Paris-Descartes University, Sorbonne Paris-Cité, Virology Laboratory, Necker Enfants-Malades Hospital, Paris bInfectious Disease Unit, Hospital Tourcoing cMedecine Unit, General Hospital Aubagne dMicrobiology Laboratory General Hospital eDepartment of Infectious Diseases, General Hospital, Toulon fVirology LaboratoryTimone hospital, Marseille, France.
authors.forename: Antoine
authors.initials: A
authors.lastname: Chéret
authors.forename: Julie
authors.initials: J
authors.lastname: Allemand
authors.forename: Cécile
authors.initials: C
authors.lastname: Poggi
authors.forename: Gilles
authors.initials: G
authors.lastname: Hittinger
authors.forename: Alain
authors.initials: A
authors.lastname: Lafeuillade
authors.forename: Catherine
authors.initials: C
authors.lastname: Tamalet
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D006259:Craniocerebral Trauma / Q000150:complications*; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D008297:Male; D008875:Middle Aged; D056990:Post-Exposure Prophylaxis / Q000379:methods* / Q000706:statistics & numerical data*
chemical_list: D044966:Anti-Retroviral Agents